The Supreme Court has sought an explanation from the ministry of health and family welfare as to why it was averse to holding clinical trial of a homoeopathic medicine, apparently meant to cure cancer patients.“Even if there is 10%t chance of its (medicine) success, you must go ahead with it. A bench of Justice BS Chauhan and Justice Swatanter Kumar said while hearing public interest litigation (PIL) wanting a court direction to the government to “commission research for it,” with homeopathic composition for cure of cancer chance of its (medicine) success,
Moved by World Homeopathic Development Organisation, the PIL claims the drug, invented by Dr AM Mathur, could be an efficacious, cost effective and safe alternative treatment for cancer patients. The petition was moved following the doctor’s failure to convince ministry of health and family welfare’s department of Ayush and Central Council for Research in Homeopathy to hold clinical trial and promote it for cancer treatment.
Though SC has also appointed a senior advocate to assist the court in adjudicating the PIL, it wants government’s official response to the petition. In reply to Dr Mathur’s representation the Ministry apparently stated that it did not promote inventions by private doctors.
“If it’s to provide an affordable treatment to cancer patients, why don’t you make an effort to promote it,” the court said while giving three weeks time to the Centre for filing a detailed response.
According to the PIL Gurgaon based Dr Mathur has been treating cancer patients with the medicine since 1999 after he got it patented with the government. He had also been issued license to manufacture and sell the medicine.
“With the help of aforesaid medicine invented by him, he had successfully treated and cured thousands of patients suffering from various kinds of cancers after they were declared incurable by different allopathic institutions,” the PIL stated.
The Central Council for Research in Homoeopathy had refused to take up Dr Mathur’s invention as it does not have facility of hospitals for clinical research, the petitioner claimed.
Bhadra Sinha, Hindustan Times
New Delhi, July 22, 2012